2,4-Diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline (TMQ), a potent non-classical folate antagonist inhibitor—I
- 1 June 1979
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 28 (12) , 1983-1987
- https://doi.org/10.1016/0006-2952(79)90655-5
Abstract
No abstract availableFunding Information
- American Cancer Society
- National Cancer Institute
This publication has 12 references indexed in Scilit:
- Dihydrofolate reductase from a resistant subline of the L1210 lymphoma. Purification by affinity chromatography and ultraviolet difference spectrophotometric and circular dichroic studiesBiochemistry, 1977
- Inhibition of mammalian dihydrofolate reductase by selected 2,4-diaminoquinazolines and related compoundsJournal of Medicinal Chemistry, 1974
- Antimalarial drugs. 24. Folate antagonists. 2. 2,4-Diamino-6-{[aralkyl and (heterocyclic)methyl]amino}quinazolines, a novel class of antimetabolites of interest in drug-resistant malaria and Chagas' diseaseJournal of Medicinal Chemistry, 1972
- DISCUSSION PAPER: NEW APPROACHES TO CHEMOTHERAPYAnnals of the New York Academy of Sciences, 1971
- DISCUSSION PAPER: STUDIES WITH A 2,4‐DIAMINO‐5‐CHLORO‐QUINAZOLINE ANTIFOLATE: IN VITRO AND IN VIVO CORRELATES IN NORMAL AND LYMPHOSARCOMA DOGSAnnals of the New York Academy of Sciences, 1971
- Quinazoline antifolates as inhibitors of dihydrofolate reductase from human leukemia cellsBiochemical Pharmacology, 1970
- Dihydrofolate Reductase from a Resistant Subline of the L1210 LymphomaJournal of Biological Chemistry, 1967
- Specific Binding of 4-Amino Folic Acid Analogues by Folic Acid ReductasePublished by Elsevier ,1961
- Crystalline Dihydropteroylglutamic AcidNature, 1960